- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05503394
A Peer Support Network System Construction for the Primary Caregivers of Children With Biliary Atresia
A Peer Support Network System Construction for the Primary Caregivers of Children With Biliary Atresia Based on Social Support Theory: A Quasi-experimental Study
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
The primary caregivers of children with biliary atresia have a heavy psychological burden, but there is a lack of supportive research on this population. Therefore, this study used a web-based peer support platform to intervene in the primary caregivers of children with biliary atresia to reduce the psychological burden of this population.
The study consisted of two parts. First, a literature analysis, semi-structured interviews, and expert validation are used to form a peer support WeChat platform for primary caregivers of children with biliary atresia.
Second, primary caregivers of children with biliary atresia are selected as the study population and divided into intervention and control groups in chronological order at a children's hospital in Shanghai. Primary caregivers who visit the hospital between August 2022 and October 2022 are assigned to the control group and primary caregivers who visit the hospital between January 2023 and March 2023 are assigned to the intervention group. The intervention group receives a peer support WeChat platform intervention on top of usual care from the day of surgery to one postoperative month. The levels of negative emotions and caregiver burden are compared between the two groups after the intervention.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Chenglu Zhang, Master
- Phone Number: +8613818249330
- Email: 2512794717@qq.com
Study Locations
-
-
Shanghai
-
Shanghai, Shanghai, China, 201100
- Children's Hospital of Fudan University
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Child was diagnosed with biliary atresia congenital type 3 and required kasai portoenterostomy ;
- Providing primary care for the child;
- Use a smartphone and have access to the internet;
- Normal communication ability;
- Volunteering to participate in the study.
Exclusion Criteria:
- Existing or previous mental illness;
- Presence of severe anxiety (SAS ≥ 70 points) or depressive mood (SDS ≥ 70 points);
- Children with comorbidities other than biliary atresia;
- Refusal to cooperate.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Peer support WeChat platform intervention group
Peer support WeChat platform intervention for primary caregivers of children with biliary atresia based on routine care during the postoperative period up to one month postoperatively
|
Primary caregivers of children with biliary atresia are selected as the study population and divided into intervention and control groups in chronological order at a children's hospital in Shanghai.
Primary caregivers who visit the hospital between August 2022 and October 2022 are assigned to the control group and primary caregivers who visit the hospital between January 2023 and March 2023 are assigned to the intervention group.
The intervention group will receive a peer support WeChat platform intervention from the day of surgery to one month postoperatively.
The level of negative emotions and caregiver burden will be compared between the two groups after the intervention.
The intervention group receives the same routine care as the control group.
Provide routine inpatient education and post-discharge follow-up to primary caregivers of biliary atresia.
|
Other: Routine nursing care group
Perform routine nursing care for primary caregivers of children with biliary atresia during the postoperative period up to one month postoperatively
|
Provide routine inpatient education and post-discharge follow-up to primary caregivers of biliary atresia.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The depression scores in primary caregivers
Time Frame: At the one month after the surgical kasai portoenterostomy
|
At the one month after surgical kasai portoenterostomy, primary caregivers' depression scores will be measured using the self-rating depression scale (SDS) by a specially-assigned person.
The SDS has a total of 20 items, and the score ranges from 25 to 100 points.
The higher the score and the more severe the depression.
|
At the one month after the surgical kasai portoenterostomy
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
The anxiety scores in primary caregivers
Time Frame: At the one month after the surgical kasai portoenterostomy
|
At the one month after surgical kasai portoenterostomy, primary caregivers' anxiety scores will be measured using the self-rating anxiety scale (SAS) by a specially-assigned person.
The SAS has a total of 20 items, and the score ranges from 25 to 100 points.
The higher the score and the more severe the anxiety .
|
At the one month after the surgical kasai portoenterostomy
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2021390
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Biliary Atresia Congenital Type 3
-
Sarah Magdy AbdelmohsenCompleted
-
RenJi HospitalUnknownBiliary Atresia Intrahepatic Syndromic FormChina
-
Yonsei UniversityCompletedBiliary Atresia, Kasai Portoenterostomy Status
-
Institute of Liver and Biliary Sciences, IndiaUnknownPortal Hypertension, Biliary AtresiaIndia
-
Yale UniversityNot yet recruiting
-
University of PittsburghNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National...Recruiting
-
Mirum Pharmaceuticals, Inc.CompletedBiliary AtresiaUnited States, United Kingdom, China, Taiwan, Germany, Poland, Singapore, Vietnam
-
Tongji HospitalUnknown
-
Holterman, Ai-Xuan, M.D.Children's National Health System; T. Rose Clinical, Inc., United States; Big...Completed
Clinical Trials on Peer support WeChat platform intervention
-
Chinese University of Hong KongUnknownHealth Behavior | Self EfficacyHong Kong
-
St. Joseph's Healthcare HamiltonCompleted
-
Harvard UniversityRecruitingSuicide | Distress, EmotionalUnited States
-
University of Cape TownCompleted
-
COPD FoundationCompletedChronic Obstructive Pulmonary Disease | Obstructive Sleep ApneaUnited States
-
Duke UniversityNational Institute of Nursing Research (NINR)CompletedObesity | Cardiovascular Disease | Cancer | Type II Diabetes | Peer Support and Chronic DiseaseUnited States
-
Universiti Putra MalaysiaNot yet recruitingTreatment Adherence and CompliancePakistan
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH)CompletedPersonality Disorders | Depression | Schizophrenia | Anxiety Disorders | Bipolar Disorder | Cognitive DisordersUnited States
-
Hospices Civils de LyonNot yet recruiting
-
The N.1 Institute for Health (N.1)AccesetCompleted